COMBANTRIN

SECTION 2: Hazards identification

Appearance: Liquid suspension

Hazard statements

Non-hazardous in accordance with international standards for workplace safety. Short Term: May cause mild eye irritation. (based on components) . Long Term: Repeat-dose studies in animals have shown a potential to cause adverse effects on gastrointestinal system, liver. Known Clinical Effects: Ingestion of this material may cause effects similar to those seen in clinical use including nausea, vomiting, abdominal cramps, anorexia, diarrhea, and constipation. Occasional, transient changes reported in liver function tests, but no liver damage seen. EU Indication of danger: Not classified Australian Hazard Classification Non-Hazardous Substance. Non-Dangerous Goods. (NOHSC): Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.